By: John Tozzi, Ike Swetlitz, Fiona Rutherford
CVS Health Corp.'s elevation of veteran David Joyner to chief executive officer failed to appease activists who want to see a bigger shift in direction at the health-care company.
Ike Swetlitz is a biotech and health reporter, contributing to various publications such as BNN Bloomberg, Yahoo Finance Australia, Bloomberg News, and The Spokesman-Review. His articles cover a range of topics including drug shortages, healthcare issues, and advancements in biotechnology. Ike's work has also been featured in publications such as Financial Post, Bloomberg Law, TIME, The Bulletin, and Fortune.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Ike Swetlitz's coverage focuses heavily on healthcare and pharmaceuticals, particularly emphasizing drug shortages, FDA announcements, and data-driven reporting. To effectively reach out to Ike, consider providing insights or data-based analysis related to the pharmaceutical industry, healthcare policies, drug shortages, or FDA regulations.
Given the prevalence of government announcements in his coverage attributes, pitches that provide expert commentary on government health policies or insightful analyses into how these policies impact the pharmaceutical industry could be well received by Ike.
Considering his extensive focus on specific companies such as Teva and Bluebird as well as broader topics like ADHD medication and cancer drugs might make him interested in receiving pitches regarding developments within these specific companies or around advancements related to ADHD medication and cancer drugs.
This information evolves through artificial intelligence and human feedback. Improve this profile .